All Pharma News
Essential Pharma Acquires Renaissance for Neuroblastoma Therapy.

Essential Pharma Acquires Renaissance for Neuroblastoma Therapy.
GLOBENEWSWIRE
09 Apr 2024
Share Share
Essential completes acquisition of Renaissance its clinical stage immunotherapy

Essential completes acquisition of Renaissance its clinical stage immunotherapy
PHARMABIZ
09 Apr 2024
Share Share
Renaissance Pharma launches today & announces the in-licensing of Hu14.18K322A

Renaissance Pharma launches today & announces the in-licensing of Hu14.18K322A
GLOBENEWSWIRE
01 Aug 2023
Share Share
Renaissance Lakewood Invests in Additional High-Speed Nasal Spray Assembly Capability

Renaissance Lakewood Invests in Additional High-Speed Nasal Spray Assembly Capability
CONTRACT PHARMA
05 Apr 2023
Share Share
The Renaissance of Small Molecule Drug Discovery

The Renaissance of Small Molecule Drug Discovery
Haydn Boehm, Dotmatics CONTRACTPHARMA
03 Aug 2022
Share Share
Renaissance SSA`s Generic Naloxone Hydrochloride Receives Approval in US

Renaissance SSA`s Generic Naloxone Hydrochloride Receives Approval in US
FDA
17 Dec 2018
Share Share
Renaissance`s Generic Dicyclomine Hydrochloride Receives Approval in US

Renaissance`s Generic Dicyclomine Hydrochloride Receives Approval in US
FDA
15 Nov 2018
Share Share
Renaissance`s Generic Neostigmine Methylsulfate Receives Approval in US

Renaissance`s Generic Neostigmine Methylsulfate Receives Approval in US
FDA
24 Aug 2018
Share Share
Renaissance’s Generic Sodium Nitroprusside Receives Approval In US

Renaissance’s Generic Sodium Nitroprusside Receives Approval In US
FDA
29 Jun 2018
Share Share
Renaissance’s Generic Succinylcholine Chloride Receives Approval In US

Renaissance’s Generic Succinylcholine Chloride Receives Approval In US
FDA
07 Jun 2018
Share Share